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Although the pathological relationship between parathyroid and 
thyroid diseases is common, an association between parathy-
roid adenoma and thyroid cancer is rare. Concomitant thyroid 
cancer in patients with primary hyperparathyroidism (pHPT) has 
been reported at varying frequencies. 
WE present here a 23-year-old man who had papillary thyroid 
carcinoma in the right thyroid lobe and a parathyroid adenoma 
in the left thyroid lobe, which were confirmed surgically. 
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Introduction
The correlation between concurrent thyroid and parathyroid 
disease was initially described in 1947 [1]. The existence of para-
thyroid adenoma resulting in primary hyperparathyroidism (pHPT) 
and concomitant thyroid papillary cancer is rare [2]. Probably 
this can be partially explained by different embryologic source 
of thyroid follicular cells and parathyroid cells. Conversely, the 
co-existence of parathyroid adenoma and medullary thyroid can-
cer (MTC) deriving from parafollicular cells is more common due 
to similar origin of both cell types. We present here a 23-year-old 
man who had papillary thyroid carcinoma in the right thyroid lobe 
and a parathyroid adenoma in the left thyroid lobe, which were 
confirmed surgically. 
Case Report
A 23-year-old man with a recent history of papillary carcinoma 
of the thyroid in the right lobe presented to our nuclear medicine 
department for 99mTc thyroid scan. Microscopic finding showed 
papillary thyroid carcinoma (mixed papillary and follicular vari-
ant) in the surgical right lobe. The patient’s past medical history 
was unremarkable. His 99mTc thyroid scan showed normal left 
lobe and isthmus in terms of shape, size, and uptake (Figure 1). 
In post-surgical thyroid laboratory findings, he had elevated serum 
calcium (10.9 mg/dl; normal range: 9–10.5 mg/dl) and low serum 
phosphate (2.3 mg/dl; normal range: 2.5–4.5 mg/dl). Serum cal-
cium and phosphate were rechecked, and hypercalcemia and 
hypophosphatemia were confirmed along with an elevated parathy-
roid hormone (PTH: 247 pg/ml; normal range: 15–65 g/ml), indicat-
ing primary hyperparathyroidism. Also, the parathyroid 99mTc-MIBI 
scan demonstrated parathyroid adenoma in the left lower pole of 
the thyroid (Figure 2). Because of above findings yielded, thyroid 
left lobectomy was also carried out and surgical cure was obtained. 
Surgical cure was confirmed by histopathologic verification of the 
removed abnormal parathyroid tissue, with a decrease of serum 
calcium and PTH levels to normal ranges.
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About one month later, the patient was treated with radio-
iodine and a post-ablation whole-body scan with 131I revealed 
just remnant thyroid tissue in thyroid bed (Figure 3). Then, six 
months post radioiodine therapy, his whole-body scan with 131I 
depicted negative study. Finally, noteworthy clinical improvement 
was achieved and he was advised to follow up with regular visits to 
our department. 
Discussion
Thyroid cancer accompanied with pHPT has been encoun-
tered in 3.1% to17% [3] of cases. The reason for this association 
is controversial. Some researchers have shown this concomitant 
as coincidental [4], whereas other authors have explained in-
Figure 1. The 99mTc thyroid scan showed normal left lobe and isth-
mus in terms of shape, size and uptake. The right lobe resected surgi-
cally
Figure 2. Parathyroid 99mTc-MIBI scan revealed parathyroid adenoma 
underlying the left lower pole of thyroid
Figure 3. The post-ablation whole-body scan with 131I depicted rem-
nant functioning thyroid tissue in the thyroid bed. No clear evidence of 
distant metastasis was noted throughout the body
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creased endogenous calcium levels or probably growth factors, 
such as epithelial growth factors and insulin-like growth factors, 
as goitrogenic factors [3, 5, 6].
In a study of 824 patients who had undergone cervical explora-
tion leads to thyroid lobectomy, thyroid carcinoma was detected in 
2.6% patients with pHPT. But, it is also remarkable that in this large 
series no synchronous development of thyroid and parathyroid 
carcinoma was seen [4].
In 2009, another patient was described: a 59-year-old man who 
had presented with severe clinical manifestations of pHPT eight 
years previously because his serum calcium was 14.4 mg/dl and 
his PTH serum level was 2.023 pg/ml. The patient was found to 
have synchronous parathyroid carcinoma on the left side as well 
as papillary thyroid carcinoma and parathyroid adenoma on the 
right side [7].
In 2011, an extremely rare maternal condition was reported 
during pregnancy. She was a 23-year-old pregnant woman re-
ferred with severe hyperemesis and weight loss at 32 gestational 
weeks [8]. She was diagnosed with pHPT because of parathyroid 
adenoma and treated with surgery where a synchronous thyroid 
papillary carcinoma was detected [8]. Previously reported pa-
tients had been considerably older in mean age. 
Although, concurrent thyroid cancer and parathyroid adenoma 
is rare, the diagnosis of this coexistence should be considered 
in pHPT because of the prevention of repeat surgery like in our 
patient. In term of localization, ultrasonography (US) can improve 
localization of thyroid nodules, and accurate diagnosis of thyroid 
nodules is performed by combining fine-needle aspiration (FNA) 
with sensitivity 89%, specificity 91%, and accuracy 90% [9]. In ad-
dition, today the 99mTc-MIBI scan is considered as a localization 
tool with the greatest sensitivity, and there are advantages, includ-
ing the detection of ectopic glands. Therefore, the combination 
of 99mTc-MIBI, US, and US-FNA (if needed) are recommended 
as the best diagnostic tool for parathyroid localization of pHPT and 
concomitant thyroid disease. However, removal of relevant thyroid 
nodules is suggested during parathyroid surgery. 
Conclusions
This case demonstrates the need for clinical alertness of 
concurrent hyperparathyroidism and thyroid cancer. Therefore, 
careful thyroid assessment is recommended for all patients with 
primary hyperparathyroidism
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